Progression-free survival as a surrogate marker of overall survival: Is it the good question?

Cancer. 2011 Jun 15;117(12):2586-7. doi: 10.1002/cncr.25955. Epub 2011 Feb 1.

Author

Bernard Escudier¹

Affiliation

¹ Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. [email protected].

PMID: 21287543
DOI: 10.1002/cncr.25955

No abstract available

Publication types

Editorial

MeSH terms

Biomarkers
Carcinoma, Renal Cell / mortality*
Disease-Free Survival
Humans
Kidney Neoplasms / mortality*

Substances

Biomarkers